Search Results - Batonga, Joëlle

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in Humans

    The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in Humans by JIANMIN DUAN, BOLGER, Gordon, KUKOLJ, George, WHITE, Peter W, BETHELL, Richard C, CORDINGLEY, Michael G, GARNEAU, Michel, AMAD, Ma'an, BATONGA, Joëlle, MONTPETIT, Hélène, OTIS, François, JUTRAS, Martin, LAPEYRE, Nicole, RHEAUME, Manon

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data

    A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data by Rioux, Nathalie, Batonga, Joëlle, Colombo, Federico, Massé, Jonathan, Zouki, Christine, Ribadeneira, Maria D., Duan, Jianmin, Bethell, Richard C.

    Published in Xenobiotica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co-Administration of the Proton-Pump Inhibitor Rabeprazole

    Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co-Administration of the Proton-Pump Inhibitor Rabeprazole by Faison, Shamia L, Batonga, Joelle, Arumugham, Thangam, Bartkus, Angela, Morrison, Marion, Mullin, Mark J, Tippin, Tim, Naderer, Odin

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    SAT-430 A Phase 1 Study in Healthy Volunteers to Assess the Safety, Tolerability, and Pharmacokinetics of ONO-5788: A Novel Oral Small Molecule Somatostatin Receptor Type-2 Agonist

    SAT-430 A Phase 1 Study in Healthy Volunteers to Assess the Safety, Tolerability, and Pharmacokinetics of ONO-5788: A Novel Oral Small Molecule Somatostatin Receptor Type-2 Agonist by Kaviya, Arpeat, O'Reilly, Terry, Batonga, Joelle, Seki, Akiteru, Beale, Dominic, Yoneda, Kazuhiro, Bruce, Mark

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: